Sunday, January 3, 2021

AIDAN asks DCGI to withdraw approval for Bharat Biotech's Covaxin

The All India Drug Action Network (AIDAN) has urged the DCGI to reconsider the recommendations of the SEC in granting the REU approval to COVAXIN. The AIDAN has said it is shocked to learn about the recommendation to grant REU approval to Bharat Biotech's COVAXIN in "clinical trial mode" and "specially in the context of infection by mutant strains".

from IndiaTV India: Google News Feed https://ift.tt/3o8d5Y4
via
at
Labels:

No comments:

Post a Comment

Please do not enter spam link in the comment box. Suggestions are invited for improvement.

Subscribe to: Post Comments (Atom)

Republic Day 2024: French band, marching contingent and Rafale jets participate in parade | WATCH

Republic Day 2024 : As India's 75th Republic Day Parade kicked off in the national capital, a 30-member band contingent and a marching c...